ET
Energy Transfer LP Common Units
stockNYSE

**BanBet Created** ▼ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **QQQ** | $700.00 (below) | $725.50 | -3.5% | Fri 4:05 AM ET |

**No Active BanBet** | W | L | Win Rate | |:---:|:---:|:---:| | 4 | 2 | 67% | *Banned from banbets until Mon 11:15 AM ET*

I currently have a rather large position in dividend stocks relative to my account size paying roughly 5% on the entire account or about 9-10% on the dividend portion. Some of the stocks I own in the dividend portion are as follows:GPIQ, JEPI, JEPQ, ET, MPLX, BXSL, NLY, and MAIN. Some of my growth portfolio stocks also pay dividends in many cases the dividends are small but it all adds up.

Hello (again!)! I have posted this before but it was removed. Not selling anything and do not want direct messages. Literally just trying to share what I've done with daytrading and looking for advice and chatter if anyone has done anything different. I’ve been building an intraday system and I’m find that outside setup ideas would help a lot more than more of my own tinkering. The following is an AI summary(for my convenience) for what I had made showing what has been done so far. I'll mark my comments as "NAI" or non-AI" Happy to share our setup list with anyone who wants to trade ideas. Also open to any feedback. Bash away! What it is Rule-based intraday trading of US stocks and ETFs. Flat by 15:55 ET, nothing held overnight. Entries are on 5-minute bar closes between 09:50 and 15:00 ET. Risk unit (R) = 0.25 × the stock’s daily ATR. Results are measured in R after costs. About 1,200 liquid names on SIP 1-minute data, executed through Alpaca. Everything is paper for now(NAI - Yes, I know the fills are instant if price touches). Real money waits until the main account shows a consistent record. I built it with an AI coding assistant doing the heavy lifting; I make the calls on what gets promoted or dropped. Accounts (6) Current Setup Allocation Primary: 14 setups. The best performers. Testing 1: 32 setups. Testing 2: 47 setups. Testing 1 and 2 hold promising candidates that need live proof. Setup Generator: 30 setups. Machine-generated, 10 new ones a night. Graveyard: 17 setups. Underperformers we keep running instead of deleting. Long-hold: one separate longer-term ETF account. That’s about 140 intraday setups live on paper, and a few hundred trades on a busy day. Backtesting (where most of the work goes) About 2 years of 1-minute data, roughly 500 sessions. A 4-month block is locked away as a one-shot final holdout, never looked at. The rest is split into training (to end of 2025) and validation (2026). A setup has to hold up in both. Costs are always in: 1 bp + $0.01/share each way, plus $0.02/share extra on stops. Every configuration tried is counted, and the pass bar gets stricter the more we try (t ≥ max(1.5, √(2 ln N))). Setups must beat random entries at the same time of day. A recent swarm of 200 dip-buying variants had zero pass. Most ideas die here, and we report the failures too. The generator screens about 3,000 rule combinations a night and keeps the top 10. Live side Setups move between accounts on their live record: trades, win rate vs. break-even win rate, avg R, and a t-stat. Avg R per trade beats win rate as the deciding number. Risk rules learned the hard way: A setup that’s down 2R on the day stops for the day. Two versions of the same setup can’t both hold the same stock. Bank half, protect the rest. Next up: replaying recorded past sessions through the live code, so new setups get \~50 “live” sessions before they ever trade. Honest status: some setups look genuinely good live, but nothing has cleared the full statistical bar yet. The main account isn’t consistently green, and paper fills are optimistic. What I’m after Intraday setups you’ve seen work or fail, especially longs that don’t just ride up days and shorts that survive up days.(NAI - My SHORTS are crushing on bad market days and neutral on up days, my LONGS skew slightly high on good market days and drop on bad market days, hence the need for more quality longs.) How you handle setups that only work in one market direction or condition. Ideas on data, fill modeling or validation. In return: our setup list in plain English (the rules, backtest numbers after costs, and live record so far), failures included.(NAI - again, literally just trying to co-op, not sell. Chill mods!) Not financial advice. Just a nerd project comparing notes. Not great with screenshots and pictures on reddit but for further questions, I'll do my best to answer with pictures or a candid response. TL;DR: Paper-trading 140 rule-based intraday stock setups across five Alpaca accounts, backtested on two years of minute data; trying to swap setups.

| Ticker | Target | Entry | Current | Move | Expires | |:---:|:---:|:---:|:---:|:---:|:---:| | **SPY** ▲ | $782.00 (above) | $768.21 | $773.09 | +1.8% | Mon 12:21 PM ET |

No. But thats cute. Are you really that fragile? No worries i got you. Fair point. I would say (thats) pedantic (because most people dont actually mean a wealth tax because that’s historically been very ineffective so people usually mean wealth colloquially) but (youre right) the CA tax is legitimately a wealth tax. (Considering this fact) then no, (i agree with your (fair) point) i dont think anyone has implemented a wealth tax. Of course theres G&ET but that is on transfer (death) and pretty easy to work around (so it may not meet your standard). We used to have GPT (which was a true wealth tax) but it was laughably ineffective and hasnt been a thing for over a century. Here are a bunch of reasons it has been historically difficult to implement a wealth tax. Is that better?

**BanBet Created** ▼ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **BE** | $227.01 (below) | $234.03 | -3.0% | Fri 9:45 PM ET |

**📊 Key U.S. Economic Data (ET)** **8:30 AM** | Unemployment Claims | Forecast: 200K | Previous: 199K ⚠️ For informational purposes only. Not financial advice. 📌 #SPY #SPX #UnemploymentClaims #Employment

9:30 ET

**BanBet Created** ▲ | **Record:** 1W - 2L | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **MU** | $987.42 (above) | $914.28 | +8.0% | Wed, Oct 28, 6:37 PM ET |

| Ticker | Target | Entry | Current | Move | Expires | |:---:|:---:|:---:|:---:|:---:|:---:| | **QQQ** ▼ | $691.03 (below) | $743.04 | $725.59 | -7.0% | Tue 10:39 AM ET |

**BanBet Created** ▼ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **AMD** | $545.73 (below) | $551.24 | -1.0% | Thu 4:34 PM ET |

cheap filter you can check right now: tag each trade by entry time. midday breaks (roughly 11:30 to 2 ET) fail a lot more since volume dries up, and I'd bet most of your failed ones sit in that window

My understanding is that your excess liquidity must always be positive, so as far as I can tell, you are already in violation, and a liquidation could happen at any moment. The SMA only applies during 3:50-5:20 p.m. ET (near the close) and it must be positive there. That's not your issue. IBKR will probably liquidate, not issue a margin call. Maybe you can close positions yourself in a way that does less damage.

📉 Semafor reports Meta plans to create nonvoting shares and sell more stock, possibly announced as soon as today (3:19 PM ET). That firms up the earlier speculation that Meta would sell stock to pay for AI spending, which means dilution and more worry about how AI spending gets funded. SPY: pressure on Meta and the Nasdaq into the close, a mild headwind for SPY. Watch for a formal announcement, likely with earnings tonight. FinancialJuice Smaller: Kyiv's mayor says the city is under ballistic missile attack (3:17 PM ET), just after Trump said a Russia-Ukraine settlement is getting closer. FirstSquawk

**BanBet Created** ▲ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **NFLX** | $69.03 (above) | $65.74 | +5.0% | Fri 2:49 PM ET |

**Levels** The most recent 15-minute swing high and swing low that had finished forming before the London open. London open is 08:00 London time converted to New York time each day, so it’s normally 03:00 ET and shifts during the weeks when US and UK daylight saving don’t line up. A swing high is a 15-minute candle whose high is strictly above the k candles on each side (swing low is the mirror). k = 2 or 3. Built from overnight and prior-day candles, up to 4 days back. **Trading window** From the London open to 16:00 ET. The first 15-minute candle after the London open can’t count as a breakout or a rejection. New entries until 15:30 ET; anything still open closes at the 15:59 ET bar. One position at a time; each level-and-setup combination trades at most once a day. **Setups** A – break and retest: a 15-minute candle closes beyond the level, then a limit order sits at the level for the retest. A break above the swing high goes long; a break below the swing low goes short. B – third rejection: while the level is unbroken, a 15-minute candle that wicks through it and closes back inside counts as one rejection. After two, the next touch is faded (short at the high, long at the low). A 15-minute close through the level cancels B, but only before entry. Once in a trade, only the stop, the target or the time exit closes it. Closes back through the level don’t, as in the author’s long example. Versions run: A only, B only, A + B. **Stops (5 versions)** SC: 1 tick beyond the breakout candle (A) or beyond the highest or lowest rejection wick (B). A1 / A15 / A2 / A3: 1×, 1.5×, 2× or 3× the average 15-minute range (the 14 candles before the London open), measured from the level. If a stop isn’t at least 1 tick from the entry, there’s no trade. **Targets (3 versions; all skip the trade unless the target is at least 2× the risk away)** TPX: exit at the next level of interest in the trade direction. That list includes every 15-minute swing from the last 4 days, the prior regular-session high and low, the overnight high and low, and round 50-point numbers. T2R: same filter, but exit at exactly 2× the risk. TOPP: rejection trades target the opposite level (a long from the swing low targets the swing high, and vice versa). Breakout trades target the next major level only: prior regular-session high/low, overnight high/low, round 50s. Added in amendment B1 after the 4-day swing list proved too crowded to allow wide stops. **Fills** Conservative (the one judged): The limit entry needs price to trade 1 tick through the level. The stop fills 1 tick worse (or at the open if price gaps through). The target needs a 1-tick trade-through. A bar that touches both stop and target counts as a stop. On the entry bar only the stop is checked. Optimistic (diagnostic only): fills on a touch, and a bar touching both counts as a win. **Grid and pass bar** 2 swing sizes × 5 stops × 3 targets × 3 setup versions = 90 versions, each with both fill modes. To pass: 150+ trades, t ≥ 3, profit factor ≥ 1.15, both 2013–19 and 2020–26 profitable, and 60%+ of years positive. The 10 best versions on 2013–19 also had to hold up on 2020–26. **The versions closest to the author’s (~1 trade a day)** Swing size 2 or 3, stop SC or A1, target TOPP, both setups. They took 205–265 trades a year, won 13–21% of the time, and lost $25–37 per trade, losing in every year from 2016–26. The author reports 38–55% win rates.

📉 The NY Post reports speculation that Meta could issue new stock to fund its AI spending (1:00 PM ET). That's only speculation, and it lands just before Meta reports tonight. It adds to the worries about how AI spending gets paid for, so it's a likely small drag through Meta and the other big tech names. LiveSquawk

**BanBet Created** ▲ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **TSLA** | $400.00 (above) | $387.35 | +3.3% | Sat 1:11 PM ET |

*— Report will be subject of New England CEPAC meeting in May 2027; Draft Scoping Document open to public comment until November 10, 2026 —* **BOSTON, October 21, 2026** – The Institute for Clinical and Economic Review ([ICER](https://icer.org/)) announced today that it will assess the comparative clinical effectiveness and value of synthetic psilocybin (COMPASS Pathways) for treatment-resistant depression. The therapy is also referred to as COMP360. The assessment will be publicly discussed during a meeting of the [New England Comparative Effectiveness Public Advisory Council (CEPAC)](https://icer.org/who-we-are/people/independent-appraisal-committees/new-england-cepac/) in May 2027, where the independent evidence review panel will deliberate and vote on evidence presented in ICER’s report. ICER’s website provides [timelines of key posting dates and public comment periods for this assessment](https://icer.org/?post_type=assessment&p=23880). Consistent with ICER’s process for announcing new assessments, we have spent the past five weeks conducting outreach and engaging with targeted stakeholders, including the manufacturer, relevant patient groups and clinical experts. Based on this preliminary cross-stakeholder engagement, today ICER has posted a [Draft Scoping Document](https://icer.org/wp-content/uploads/2026/10/ICER_TRD_Draft-Scope_For-Publication_102126-1.pdf)outlining how we plan to conduct this assessment.    All interested stakeholders are encouraged to submit comments and suggested refinements to the scope to ensure all perspectives are adequately considered. Comments can be submitted by email to [publiccomments@icer.org](mailto:publiccomments@icer.org) and must be received by 5 PM ET on November 10, 2026. Please submit public comments as a Word document in the following format:   ICER’s [Patient Portal](https://icer.org/patients/) and [Manufacturer Engagement Guide](https://icer.org/wp-content/uploads/2025/09/ICER_Mfr_Engagement_Guide_01062026.pdf) provide additional guidance for submitting public comments, including suggestions for what types of information may be most useful. In addition to comments on the scope, ICER also welcomes submissions from stakeholders on examples of low-value care practices within this clinical area. These submissions will inform a report section focused on strategies to reduce waste and preserve resources for high-value, potentially higher-cost treatments. More information is available in the scoping document. Following the public comment period, a revised scoping document will be posted on or about November 18, 2026. **About ICER** The Institute for Clinical and Economic Review ([ICER](https://icer.org/)) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends solutions to ensure fair access to prescription drugs. For more information about ICER, please visit [www.icer.org](http://www.icer.org/).

| Ticker | Target | Entry | Current | Move | Expires | |:---:|:---:|:---:|:---:|:---:|:---:| | **AMZN** ▲ | $274.37 (above) | $249.43 | $263.41 | +10.0% | Thu, Nov 5, 7:24 AM ET | | **Record** | 1W - 3L | 25% | - | - | - |

[r/mutualfunds > Wiki](https://www.reddit.com/r/mutualfunds/wiki/index/): [ET Money Blog: Daily or weekly SIPs don’t enhance your returns significantly.](https://www.etmoney.com/learn/mutual-funds/which-is-better-daily-or-weekly-or-monthly-sip/)

Thank you for sharing this experience with us. We strongly encourage you to connect with our Pensions team over the phone, generally available Monday through Friday from 8:30 a.m. to 8:00 p.m. ET, through the following link. Please say "Pensions" when prompted to be routed appropriately. [Contact Us](https://www.fidelity.com/customer-service/contact-us) Please let us know if you have other questions.

**BanBet Created** ▲ | **Record:** 2W - 0L | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **RDDT** | $180.00 (above) | $158.15 | +13.8% | Wed, Oct 28, 11:21 AM ET |

**BanBet Created** ▼ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **MU** | $850.00 (below) | $904.71 | -6.0% | Mon 10:06 AM ET |